BACKGROUND Hirsutism, defined by the presence of excessive terminal hair in androgen-
sensitive areas of the female body, is one of the most common disorders in women during …

Objective: Our objective was to develop clinical practice guidelines for the evaluation and
treatment of hirsutism in premenopausal women. Participants: The Task Force was …

Abstract Objective To update the “Evaluation and Treatment of Hirsutism in Premenopausal
Women: An Endocrine Society Clinical Practice Guideline,” published by the Endocrine …

Hirsutism is the excessive growth of terminal hair in a typical male pattern in a female. It is
often a sign of excessive androgen levels. Although many conditions can lead to hirsutism …

Polycystic ovary syndrome (PCOS) is a complex phenotypic spectrum of primarily
hyperandrogenic signs and symptoms. PCOS is the most common endocrine disturbance to …

Androgen-mediated cutaneous disorders (AMCDs) in women, including acne, hirsutism, and
female pattern hair loss, can be treated with hormone-modulating therapies. In the second …

Hirsutism (unwanted male pattern hair growth in women) is common. Approximately 10% of
reproductive age women have hirsutism. Much expense is involved in removing unwanted …

Polycystic ovarian syndrome (PCOS) prevails in approximately 33% of females of
reproductive age globally. Although the root cause of the disease is unknown, attempts are …

Background Hirsutism occurs in 5% to 10% of women of reproductive age when there is
excessive terminal hair growth in androgen‐sensitive areas (male pattern). It is a distressing …

Objective To evaluate the efficacy of various drug treatments in common use for hirsutism in
women. Design A systematic review of published randomized controlled trials (RCTs). We …